Surrozen SRZN
NASDAQ SRZN
$32.18 +0.20 (+0.63%)
At close: Sep 30, 2026 · 4:00 PM EDT

Surrozen (SRZN) Total Non-Current Liabilities (2020 - 2026)

Updated

Surrozen (SRZN) posted Total Non-Current Liabilities of $138 million for Q2 2026, up 501.0% from $22.96 million a year earlier but down 15.5% from the prior quarter.

Analysis

Surrozen (SRZN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Surrozen's Total Non-Current Liabilities came in at $127.83 million, up 816.0% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
  • In prior years, Surrozen's Total Non-Current Liabilities was $13.96 million in FY2024 (+73.8%), $8.03 million in FY2023 (-38.7%), $13.11 million in FY2022 (-31.6%) and $19.17 million in FY2021 (+29.8%).
  • Quarterly Total Non-Current Liabilities has run from a low of $5.98 million in Q2 2024 to a high of $163.34 million in Q1 2026 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last seven quarters, with growth averaging 450.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2025, with growth of 946.0%; the weakest was Q2 2022, with a decline of 79.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $163.34 million (Q1 2026), $127.83 million (Q4 2025) and $64.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Surrozen 378.24 Mn 378.24 Mn - 138.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.00 Mn
Mar 31, 2026 163.34 Mn
Dec 31, 2025 127.83 Mn
Sep 30, 2025 64.02 Mn
Jun 30, 2025 22.96 Mn
Mar 31, 2025 59.78 Mn
Dec 31, 2024 13.96 Mn
Sep 30, 2024 6.12 Mn
Jun 30, 2024 5.98 Mn
Mar 31, 2024 6.40 Mn
Dec 31, 2023 8.03 Mn
Sep 30, 2023 8.20 Mn
Jun 30, 2023 8.62 Mn
Mar 31, 2023 10.57 Mn
Dec 31, 2022 13.11 Mn
Sep 30, 2022 12.61 Mn
Jun 30, 2022 13.05 Mn
Mar 31, 2022 13.19 Mn
Dec 31, 2021 19.17 Mn
Sep 30, 2021 18.60 Mn
API Access

Surrozen Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SRZN&period=max&api_key=YOUR_API_KEY